Shawn Harmon, a barrister and widely published researcher, is Lecturer in Regulation & Risk in the School of Law at the University of Edinburgh, UK. He is associated with the J Kenyon Mason Institute in Medicine, Life Sciences and the Law, the ESRC Centre for Social and Economic Research on Innovation in Genomics (Innogen), and the AHRC Research Centre in Intellectual Property and Technology Law (SCRIPT).
Dr. Harmon's research encompasses issues related to the governance and regulation of health and emerging technologies. He is concerned with a variety of ethico-legal issues in medical practice, medical research and biotechnology innovation (consent, privacy, access, etc.), and the interaction of the research and governance setting with commercial interests (particularly intellectual property). Past work has examined the role of bioethical values, human rights, and science and medical regulatory instruments, domestic and international, in the biobank, stem cell research, and public health settings. Dr. Harmon graduated from Saint Mary's University (BA, 1993), University of New Brunswick (LLB, 1996), and University of Edinburgh (LLM, 2004; PhD, 2011).